Sign in
Taking people in South KoreaNo phase

Remimazolam versus propofol and confusion after hip or knee surgery in older adults

Compares remimazolam and propofol anesthesia for delirium after orthopedic surgery in older patients.

Key facts

Who runs it
Inje University
Where
Seoul, South KoreaSee the site
Trial code
Registry title
Effect of Remimazolam and Propofol on Postoperative Delirium
Status
Recruiting
People taking part
82 people, planned
Started
1 Aug 2022
Planned end
30 Sept 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Remimazolam (Byfavo)
  • Propofol
Record updated
27 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for older people having hip or knee joint replacement surgery under general anesthesia. It compares two anesthesia drugs, remimazolam and propofol, for confusion after surgery (delirium).

Age
65 Years to 100 Years
Sex
All sexes
Disease stage
People having hip or knee joint replacement (arthroplasty) under general anesthesia. Body mass index must be >30 kg/m2.
Earlier treatment
People cannot join if they took benzodiazepines, anti-anxiety drugs, antidepressants or antipsychotic drugs within 24 hours.

Main reasons for not taking part

  • Moderate to severe liver or kidney problems
  • Breathing tube cannot be removed in the operating room after surgery
  • Dependence on benzodiazepines, or sensitivity to the anesthesia drugs used in the trial
  • Acute angle glaucoma or acute psychotic depression
  • Past stroke or other disease of the brain's blood vessels

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • elderly patients undergoing hip or knee arthroplasty under general anesthesia
  • body mass index >30 kg/m2

Who cannot take part

  • sensitivity to anesthetic drugs used for study (Benzodiazepines, Propofol, Remifentanil, Fentanyl citrate, Rocuronium bromide, Sugammadex, Flumazenil)
  • received (benzodiazepine, antianxiety drugs, antidepressant, antipsychotic drugs) within 24 hours
  • history stroke or cerebrovascular disease
  • moderate to severe liver dysfunction
  • moderate to severe renal dysfunction
  • unable to extubate in the operation room after operation
  • benzodiazepine dependence
  • acute angle glaucoma
  • acute psychotic depression

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 65 and 100 years old?

Where in South Korea

  • Sanggye Paik hospitalSeoul, South KoreaContact: In-Jung JunTaking people

About the trial

What the trial wants to find out

Remimazolam is an ultra-short acting benzodiazepine agonist which is used widely for general anesthesia and sedation. Remimazolam has several advantages. Remimazolam is rapidly metabolized by tissue esterase that it does not accumulate even after infusion for long periods of time. The presence of reversal agents (flumazenil) is also advantageous. Also, hemodynamic stability compared to propofol gives clinicians preference to use for geriatric anesthesia. However, the study on the effect of remimazolam compared to propofol on postoperative delirium have not been carried out. The purpose of the study is to compare the incidence of postoperative delirium and recovery profile in elderly patients undergoing orthopedic surgery using either remimazolam or propofol.

The 2 groups in the trial

  • Remimazolam groupTreatment being tested

    Remimazolam is started during induction of anesthesia at the rate of 6 mg/kg/hr and continued at the rate of 1 mg/kg/hr (within 0.3-2 mg/kg/hr). Remimazolam is stopped 20 minutes before end of operation.

    Treatment: Remimazolam (Byfavo)

  • Propofol groupExisting treatment, for comparison

    Propofol is continuously infused within 1-5 μg/mL.

    Treatment: Propofol

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of Remimazolam and Propofol on Postoperative Delirium in Elderly Patients Undergoing Hip and Knee Surgery
Plain-language title
Remimazolam versus propofol and confusion after hip or knee surgery in older adultsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT05514405, who can take part
Record updated
27 March 2026